HK3 was also predominantly expressed in macrophages in ovarian serous cystadenocarcinoma (OV), pancreatic adenocarcinoma (PAAD), SKCM, LIHC, non-small cell lung cancer (NSCLC), head and neck squamous cell carcinoma (HNSC), KIRC, carcinoma of colon and rectum (CRC), breast invasive carcinoma (BRCA), chronic lymphocytic leukemia (CLL), and cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC) (Supplementary Figures S4–S7). Here, HK3 is linked to pancreatic adenocarcinoma.